Palomar Medical Technologies, LLC Sustainability Profile
Palomar Medical Technologies, LLC, headquartered in the United States, is a leading innovator in the aesthetic and medical laser industry. Founded in 1991, the company has established itself as a pioneer in developing advanced laser and light-based technologies for skin rejuvenation, hair removal, and other dermatological applications. With a strong presence in North America and expanding operations globally, Palomar is renowned for its cutting-edge products, including the StarLux® and Icon™ systems, which are distinguished by their versatility and efficacy. The company’s commitment to research and development has positioned it as a trusted name in the market, achieving notable milestones such as FDA clearances and numerous industry awards. Palomar Medical Technologies continues to shape the future of aesthetic medicine with its innovative solutions and dedication to quality.
DitchCarbon Score
How does Palomar Medical Technologies, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Palomar Medical Technologies, LLC's score of 61 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Palomar Medical Technologies, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Hologic, Inc., which may influence its climate commitments and reporting practices. As part of its corporate family relationship, Palomar Medical Technologies inherits climate initiatives and targets from Hologic, Inc. However, there are no documented reduction targets or climate pledges specific to Palomar Medical Technologies. The absence of data suggests that the company may still be in the process of establishing its own emissions reporting framework or reduction strategies. In the context of the industry, it is essential for companies like Palomar Medical Technologies to align with broader climate commitments, particularly those set by their parent company, Hologic, Inc. This alignment may include adherence to science-based targets and participation in initiatives such as the Carbon Disclosure Project (CDP). Overall, while specific emissions data and reduction targets are not available for Palomar Medical Technologies, its relationship with Hologic, Inc. positions it within a framework of potential climate action and accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
How Carbon Intensive is Palomar Medical Technologies, LLC's Industry?
How Carbon Intensive is Palomar Medical Technologies, LLC's Location?
Palomar Medical Technologies, LLC's Scope 3 Categories Breakdown
Palomar Medical Technologies, LLC's Scope 3 emissions, which decreased by 10% last year and decreased by approximately 10% since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
Palomar Medical Technologies, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Palomar Medical Technologies, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
